| DNA methylation in cancer: too much, but also too little | 2002/08/05 | English | 1,002 |
| The role of cyclooxygenases in inflammation, cancer, and development | 1999/12/20 | English | 999 |
| Autophagy as a cell death and tumor suppressor mechanism | 2004/04/12 | English | 997 |
| Glycolysis inhibition for anticancer treatment | 2006/08/07 | English | 997 |
| Perturbations of the AKT signaling pathway in human cancer | 2005/11/14 | English | 984 |
| 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy | 2002/08/05 | English | 974 |
| Circular RNAs in cancer: opportunities and challenges in the field | 2017/10/09 | English | 941 |
| FOXO transcription factors at the interface between longevity and tumor suppression | 2005/11/14 | English | 940 |
| Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer | 2009/11/02 | English | 920 |
| The EGF receptor family as targets for cancer therapy | 2000/12/27 | English | 920 |
| Control of apoptosis by Rel/NF-κB transcription factors | 1999/11/22 | English | 910 |
| The role of STATs in transcriptional control and their impact on cellular function | 2000/05/25 | English | 907 |
| Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression | 2004/04/19 | English | 897 |
| Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors | 2000/05/25 | English | 890 |
| The role of glutathione-S-transferase in anti-cancer drug resistance | 2003/10/20 | English | 885 |
| The FoxO code | 2008/04/07 | English | 875 |
| PI3K/Akt and apoptosis: size matters | 2003/12/08 | English | 873 |
| Cell death by mitotic catastrophe: a molecular definition | 2004/04/12 | English | 871 |
| Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis | 2002/03/21 | English | 865 |
| Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways | 2005/11/14 | English | 863 |
| NF-κB and the immune response | 2006/10/30 | English | 859 |
| How NF-κB is activated: the role of the IκB kinase (IKK) complex | 1999/11/22 | English | 845 |
| Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis | 2008/10/27 | English | 827 |
| Aberrant rel/nfkb genes and activity in human cancer | 1999/11/22 | English | 827 |
| Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues | 2005/12/05 | English | 822 |
| MYC oncogenes and human neoplastic disease | 1999/05/13 | English | 805 |
| CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future | 2002/08/05 | English | 804 |
| Immunogenic death of colon cancer cells treated with oxaliplatin | 2009/11/02 | English | 799 |
| The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition | 2007/05/14 | English | 797 |
| A decade of caspases | 2003/11/24 | English | 785 |